Lataa...
Effects of CTLA4-Ig on human monocytes
BACKGROUND: Abatacept, a CTLA4-Ig fusion protein attenuates T cell activation by inhibiting the CD80/86-CD28 costimulatory pathway that is required for the proper T cell activation and thus displays beneficial effects in the treatment of rheumatoid arthritis (RA). Although some studies have disclose...
Tallennettuna:
| Julkaisussa: | Inflamm Regen |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5725919/ https://ncbi.nlm.nih.gov/pubmed/29259723 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s41232-017-0054-5 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|